http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9807682-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-20
filingDate 1998-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39f7d765d148cb1edb87298790fb0c73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d1918af64390922e41bd717cf9c7ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c52189c1ef124d4c06ff2eb6386021c
publicationDate 2000-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9807682-A
titleOfInvention Compound, use thereof, pharmaceutical composition, and processes for treating inflammatory conditions and immune disorders in a patient to prepare a compound.
abstract "COMPOUND, USE OF THE SAME, PHARMACEUTICAL COMPOSITION, AND, PROCESSES TO TREAT INFLAMMATORY CONDITIONS AND IMMUNOLOGICAL DISORDERS IN A PATIENT AND TO PREPARE A COMPOUND". A compound of formula (I) or a solvate thereof, wherein: X is -O- or -NH-; Q is (-CH ~ 2 ~ -) ~ p ~, (-CH = CH-) ~ p ~, (-C <154> C-) ~ p ~ where p is an integer from 0 to 4; R ^ 1 ^ is hydrogen or methyl; R ^ 2 ^ and R ^ 3 ^ independently represent O or S; n is an integer from 1 to 50; and R is hydrogen or methyl. This series of esters and complex amides of the selected phenyl xanthine derivatives inhibit the expression of adhesion molecules in the human umbilical endothelium vein cell (HUVEC) monolayers at very low concentrations and which are therefore indicated for the treatment of inflammatory conditions and immunological disorders.
priorityDate 1997-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12295530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410390849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 42.